Instituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori

Site:	Instituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori
Address:
City:	Meldola
State:
Zip:
Country:	Italy

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501